Skip to content

Clinical trials

Castleman Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Castleman Disease Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20091
20112
20121
20141
20163
20171
20181
20191
20201
20213
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed5
Terminated3
Unknown status2
Withdrawn2
Suspended1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pennsylvania4
National Cancer Institute (NCI)2
Assistance Publique - Hôpitaux de Paris1
Case Comprehensive Cancer Center1
Castleman Disease Collaborative Network1
Centocor, Inc.1
Charles University, Czech Republic1
Cylene Pharmaceuticals1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
French National Agency for Research on AIDS and Viral Hepatitis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Castleman Disease22
Sarcoma, Kaposi5
Multiple Myeloma4
Acquired Immunodeficiency Syndrome2
Amyloidosis2
Breast Neoplasms2
Cryoglobulinemia2
Hyperplasia2
Leukemia, Plasma Cell2
Lymphoma, Non-Hodgkin2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.